Markel Group
MKL
#944
Rank
$25.73 B
Marketcap
$2,034
Share price
-0.33%
Change (1 day)
11.75%
Change (1 year)
Markel Corporation is a holding company for insurance, reinsurance, and investment operations around the world.

Markel Group - 10-Q quarterly report FY


Text size:
Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 


 

xQuarterly report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2004

 

or

 

¨Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from             to             

 

Commission File Number 001-15811

 


 

MARKEL CORPORATION

(Exact name of registrant as specified in its charter)

 


 

Virginia 54-1959284
(State or other jurisdiction of
incorporation or organization)
 (I.R.S. employer
identification number)

 

4521 Highwoods Parkway, Glen Allen, Virginia 23060-6148

(Address of principal executive offices)

(Zip code)

 

(804) 747-0136

(Registrant’s telephone number, including area code)

 

NONE

(Former name, former address and former fiscal year,

if changed since last report)

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    Yes  x    No  ¨

 

Number of shares of the registrant’s common stock outstanding at October 29, 2004: 9,847,253

 



Table of Contents

Markel Corporation

Form 10-Q

Index

 

      Page Number

PART I.FINANCIAL INFORMATION

   

Item 1.Financial Statements

   
   

Consolidated Balance Sheets— September 30, 2004 and December 31, 2003

  3
   

Consolidated Statements of Operations and Comprehensive Income (Loss)— Quarters and Nine Months Ended September 30, 2004 and 2003

  4
   

Consolidated Statements of Changes in Shareholders’ Equity— Nine Months Ended September 30, 2004 and 2003

  5
   

Consolidated Statements of Cash Flows— Nine Months Ended September 30, 2004 and 2003

  6
   

Notes to Consolidated Financial Statements

  7

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations

  14
   

Critical Accounting Policies

  14

Item 3.Quantitative and Qualitative Disclosures About Market Risk

  19

Item 4.Controls and Procedures

  20

Safe Harbor and Cautionary Statement

  20

PART II.OTHER INFORMATION

   

Item 6. Exhibits

  21

Signatures

  22

Exhibit Index

  23

 

2


Table of Contents

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

MARKEL CORPORATION AND SUBSIDIARIES

 

Consolidated Balance Sheets

 

   September 30,
2004


  December 31,
2003


 
   (dollars in thousands) 

ASSETS

         

Investments, available-for-sale, at estimated fair value:

         

Fixed maturities (amortized cost of $4,171,190 in 2004 and $3,840,339 in 2003)

  $4,267,467  $3,926,652 

Equity securities (cost of $755,752 in 2004 and $638,445 in 2003)

   1,088,883   968,777 

Short-term investments (estimated fair value approximates cost)

   205,533   82,012 
   


 


Total Investments, Available-For-Sale

   5,561,883   4,977,441 
   


 


Cash and cash equivalents

   356,623   372,511 

Receivables

   464,458   450,920 

Reinsurance recoverable on unpaid losses

   1,618,605   1,614,114 

Reinsurance recoverable on paid losses

   112,637   156,493 

Deferred policy acquisition costs

   211,887   200,284 

Prepaid reinsurance premiums

   182,589   213,403 

Intangible assets

   342,617   357,317 

Other assets

   243,204   189,750 
   


 


Total Assets

  $9,094,503  $8,532,233 
   


 


LIABILITIES AND SHAREHOLDERS’ EQUITY

         

Unpaid losses and loss adjustment expenses

  $5,347,851  $4,929,713 

Unearned premiums

   1,069,305   1,060,188 

Payables to insurance companies

   94,654   150,159 

Convertible notes payable (estimated fair value of $111,000 in 2004 and $99,000 in 2003)

   93,829   90,601 

Senior long-term debt (estimated fair value of $660,000 in 2004 and $562,000 in 2003)

   609,761   521,510 

Junior Subordinated Deferrable Interest Debentures (estimated fair value of $165,000 in 2004 and $153,000 in 2003)

   150,000   150,000 

Other liabilities

   223,153   247,783 
   


 


Total Liabilities

   7,588,553   7,149,954 
   


 


Shareholders’ equity:

         

Common stock

   741,978   737,356 

Retained earnings

   486,794   375,041 

Accumulated other comprehensive income

         

Net unrealized holding gains on fixed maturities and equity securities, net of tax expense of $150,293 in 2004 and $145,826 in 2003

   279,115   270,819 

Cumulative translation adjustments, net of tax benefit of $1,043 in 2004 and $505 in 2003

   (1,937)  (937)
   


 


Total Shareholders’ Equity

   1,505,950   1,382,279 

Commitments and contingencies

         
   


 


Total Liabilities and Shareholders’ Equity

  $9,094,503  $8,532,233 
   


 


 

See accompanying notes to consolidated financial statements.

 

3


Table of Contents

MARKEL CORPORATION AND SUBSIDIARIES

 

Consolidated Statements of Operations and Comprehensive Income (Loss)

 

   Quarter Ended
September 30,


  Nine Months Ended
September 30,


 
   2004

  2003

  2004

  2003

 
   (dollars in thousands, except per share data) 

OPERATING REVENUES

                 

Earned premiums

  $521,985  $475,995  $1,542,803  $1,347,221 

Net investment income

   51,222   46,379   147,910   137,079 

Net realized gains (losses) from investment sales

   (253)  (7,360)  6,937   35,843 
   


 


 


 


Total Operating Revenues

   572,954   515,014   1,697,650   1,520,143 
   


 


 


 


OPERATING EXPENSES

                 

Losses and loss adjustment expenses

   381,802   378,868   1,009,930   938,820 

Underwriting, acquisition and insurance expenses

   169,255   147,102   491,012   420,895 

Amortization of intangible assets

   —     —     —     4,127 
   


 


 


 


Total Operating Expenses

   551,057   525,970   1,500,942   1,363,842 
   


 


 


 


Operating Income (Loss)

   21,897   (10,956)  196,708   156,301 

Interest expense

   14,495   13,720   40,317   38,756 
   


 


 


 


Income (Loss) Before Income Taxes

   7,402   (24,676)  156,391   117,545 

Income tax expense (benefit)

   (6,423)  (8,143)  41,253   38,790 
   


 


 


 


Net Income (Loss)

  $13,825  $(16,533) $115,138  $78,755 
   


 


 


 


OTHER COMPREHENSIVE INCOME (LOSS)

                 

Unrealized gains (losses) on securities, net of taxes:

                 

Net holding gains (losses) arising during the period

  $56,133  $(13,224) $12,805  $82,705 

Less reclassification adjustments for gains (losses) included in net income (loss)

   165   4,784   (4,509)  (23,298)
   


 


 


 


Net unrealized gains (losses)

   56,298   (8,440)  8,296   59,407 

Currency translation adjustments, net of taxes

   (289)  (2,750)  (1,000)  3,975 
   


 


 


 


Total Other Comprehensive Income (Loss)

   56,009   (11,190)  7,296   63,382 
   


 


 


 


Comprehensive Income (Loss)

  $69,834  $(27,723) $122,434  $142,137 
   


 


 


 


NET INCOME (LOSS) PER SHARE

                 

Basic

  $1.40  $(1.68) $11.69  $8.00 

Diluted

  $1.40  $(1.68) $11.68  $7.99 
   


 


 


 


 

See accompanying notes to consolidated financial statements.

 

4


Table of Contents

MARKEL CORPORATION AND SUBSIDIARIES

 

Consolidated Statements of Changes in Shareholders’ Equity

 

   Nine Months Ended
September 30,


 
   2004

  2003

 
   (dollars in thousands) 

COMMON STOCK

         

Balance at beginning of period

  $737,356  $736,246 

Issuance of common stock and other equity transactions

   4,622   798 
   


 


Balance at end of period

  $741,978  $737,044 
   


 


RETAINED EARNINGS

         

Balance at beginning of period

  $375,041  $251,568 

Net income

   115,138   78,755 

Repurchase of common stock

   (3,385)  (1)
   


 


Balance at end of period

  $486,794  $330,322 
   


 


ACCUMULATED OTHER COMPREHENSIVE INCOME

         

Unrealized gains:

         

Balance at beginning of period

  $270,819  $179,170 

Net unrealized holding gains arising during the period, net of taxes

   8,296   59,407 
   


 


Balance at end of period

   279,115   238,577 

Cumulative translation adjustments:

         

Balance at beginning of period

   (937)  (7,873)

Currency translation adjustments, net of taxes

   (1,000)  3,975 
   


 


Balance at end of period

   (1,937)  (3,898)
   


 


Balance at end of period

  $277,178  $234,679 
   


 


SHAREHOLDERS’ EQUITY AT END OF PERIOD

  $1,505,950  $1,302,045 
   


 


 

See accompanying notes to consolidated financial statements.

 

5


Table of Contents

MARKEL CORPORATION AND SUBSIDIARIES

 

Consolidated Statements of Cash Flows

 

   Nine Months Ended
September 30,


 
   2004

  2003

 
   (dollars in thousands) 

OPERATING ACTIVITIES

         

Net Income

  $115,138  $78,755 

Adjustments to reconcile net income to net cash provided by operating activities

   378,747   371,997 
   


 


Net Cash Provided By Operating Activities

   493,885   450,752 
   


 


INVESTING ACTIVITIES

         

Proceeds from sales of fixed maturities and equity securities

   2,066,299   3,398,346 

Proceeds from maturities, calls and prepayments of fixed maturities

   158,575   185,442 

Cost of fixed maturities and equity securities purchased

   (2,690,032)  (4,141,915)

Net change in short-term investments

   (123,521)  (36,212)

Other

   (5,447)  (3,294)
   


 


Net Cash Used By Investing Activities

   (594,126)  (597,633)
   


 


FINANCING ACTIVITIES

         

Additions to senior long-term debt

   196,816   247,282 

Repayments and repurchases of senior long-term debt

   (110,000)  (175,000)

Repurchase of common stock

   (3,385)  (1)

Other

   922   798 
   


 


Net Cash Provided By Financing Activities

   84,353   73,079 
   


 


Decrease in cash and cash equivalents

   (15,888)  (73,802)

Cash and cash equivalents at beginning of period

   372,511   444,236 
   


 


CASH AND CASH EQUIVALENTS AT END OF PERIOD

  $356,623  $370,434 
   


 


 

See accompanying notes to consolidated financial statements.

 

6


Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

1. Principles of Consolidation

 

The consolidated balance sheet as of September 30, 2004, the related consolidated statements of operations and comprehensive income (loss) for the quarters and nine months ended September 30, 2004 and 2003, the consolidated statements of changes in shareholders’ equity and the consolidated statements of cash flows for the nine months ended September 30, 2004 and 2003, are unaudited. In the opinion of management, all adjustments necessary for fair presentation of such consolidated financial statements have been included. Such adjustments consist only of normal recurring items. Interim results are not necessarily indicative of results of operations for the full year. The consolidated balance sheet as of December 31, 2003 was derived from the Company’s audited annual consolidated financial statements.

 

The consolidated financial statements and notes are presented as permitted by Form 10-Q, and do not contain certain information included in the Company’s annual consolidated financial statements and notes. Readers are urged to review the Company’s 2003 annual report on Form 10-K for a more complete description of the Company’s business and accounting policies.

 

Certain reclassifications of prior year’s amounts have been made to conform with 2004 presentations.

 

2. Net Income (Loss) Per Share

 

Net income (loss) per share was determined by dividing net income (loss) by the applicable shares outstanding (in thousands):

 

   Quarter Ended
September 30,


  Nine Months Ended
September 30,


   2004

  2003

  2004

  2003

Net income (loss), as reported (basic and diluted)

  $13,825  $(16,533) $115,138  $78,755
   

  


 

  

Average common shares outstanding

   9,847   9,845   9,850   9,841

Dilutive potential common shares

   7   —     5   18
   

  


 

  

Average diluted shares outstanding

   9,854   9,845   9,855   9,859
   

  


 

  

 

3. Stock Compensation Plans

 

The Company applies the intrinsic value recognition and measurement principles of Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock Issued to Employees, and related interpretations, in accounting for stock-based compensation plans. The Company has adopted the disclosure-only provisions of Financial Accounting Standards Board Statement (Statement) No. 123, Accounting for Stock-Based Compensation, as amended.

 

Stock-based compensation cost, net of taxes, included in net income (loss) under APB Opinion No. 25 was $0.2 million and $0.9 million, respectively, for the quarter and nine months ended September 30, 2004 and $0.1 million and $0.5 million, respectively, for the same periods in 2003. Under the fair value method principles of Statement No. 123, pro forma stock-based compensation cost, net of taxes, and pro forma net income (loss) would not have differed from reported amounts for the quarters and nine months ended September 30, 2004 and 2003.

 

7


Table of Contents

4. Reinsurance

 

The table below summarizes the effect of reinsurance on premiums written and earned (dollars in thousands):

 

   Quarter Ended September 30,

 
   2004

  2003

 
   Written

  Earned

  Written

  Earned

 

Direct

  $617,669  $605,395  $645,600  $595,705 

Assumed

   22,102   38,413   25,834   29,578 

Ceded

   (114,366)  (121,823)  (147,650)  (149,288)
   


 


 


 


Net premiums

  $525,405  $521,985  $523,784  $475,995 
   


 


 


 


   Nine Months Ended September 30,

 
   2004

  2003

 
   Written

  Earned

  Written

  Earned

 

Direct

  $1,796,525  $1,811,796  $1,814,409  $1,707,705 

Assumed

   140,880   117,506   120,616   92,379 

Ceded

   (356,068)  (386,499)  (460,407)  (452,863)
   


 


 


 


Net premiums

  $1,581,337  $1,542,803  $1,474,618  $1,347,221 
   


 


 


 


 

Incurred losses and loss adjustment expenses are net of reinsurance recoverables (ceded incurred losses and loss adjustment expenses) of $102.1 million and $56.3 million, respectively, for the quarters ended September 30, 2004 and 2003 and $246.2 million and $156.4 million, respectively, for the nine months ended September 30, 2004 and 2003.

 

5. Junior Subordinated Deferrable Interest Debentures (8.71% Junior Subordinated Debentures)

 

On January 8, 1997, the Company arranged the sale of $150 million of Company-Obligated Mandatorily Redeemable Preferred Capital Securities (8.71% Capital Securities) issued under an Amended and Restated Declaration of Trust dated January 13, 1997 (the Declaration) by Markel Capital Trust I (the Trust), a statutory business trust sponsored and wholly-owned by the Company. Proceeds from the sale of the 8.71% Capital Securities were used to purchase the Company’s 8.71% Junior Subordinated Debentures due January 1, 2046, issued to the Trust under an indenture dated January 13, 1997 (the Indenture). The 8.71% Junior Subordinated Debentures are the sole assets of the Trust. The Company has the right to defer interest payments on the 8.71% Junior Subordinated Debentures for up to five years. The 8.71% Capital Securities and related 8.71% Junior Subordinated Debentures are redeemable by the Company on or after January 1, 2007. Taken together, the Company’s obligations under the Debentures, the Indenture, the Declaration and a guarantee made by the Company provide, in the aggregate, a full, irrevocable and unconditional guarantee of payments of distributions and other amounts due on the 8.71% Capital Securities. No other subsidiary of the Company guarantees the 8.71% Junior Subordinated Debentures or the 8.71% Capital Securities. In the event of default under the Indenture, the Trust may not make distributions on, or repurchases of, the Trust’s common securities. During a period in which the Company elects to defer interest payments or in the event of default under the Indenture, the Company may not make distributions on, or repurchases of, the Company’s capital stock or debt securities ranking equal or junior to the 8.71% Junior Subordinated Debentures.

 

8


Table of Contents

6. Convertible Notes Payable

 

During 2001, the Company issued $408.0 million principal amount at maturity, $112.9 million net proceeds, of Liquid Yield Option Notes(LYONs). The LYONs are zero coupon senior notes convertible into the Company’s common shares under certain conditions, with an initial conversion price of $243.53 per common share. The issue price of $283.19 per LYON represented a yield to maturity of 4.25%. The LYONs mature on June 5, 2031. The Company uses the effective yield method to recognize the accretion of discount from the issue price to the face amount of the LYONs at maturity. The accretion of discount is included in interest expense.

 

The Company’s potential obligation to accrue contingent additional principal terminated in accordance with the terms of the LYONs on June 5, 2004.

 

The Company will pay contingent cash interest to the holders of the LYONs during the six-month period commencing June 5, 2006 and during any six-month period thereafter if the average market price of a LYON for a specified period equals or exceeds 120% of the sum of the issue price and accrued original issue discount of the LYON.

 

Each LYON will be convertible into 1.1629 shares of common stock upon the occurrence of any of the following events: if the closing price of the Company’s common shares on the New York Stock Exchange exceeds specified levels, if the credit rating of the LYONs is reduced below specified levels, if the Company calls the LYONs for redemption, or if the Company is party to certain mergers or consolidations. The shares that would be issued if the LYONs were converted are not included in the Company’s calculation of diluted earnings per share for the quarter and nine months ended September 30, 2004 and 2003, as none of the conversion events had occurred. See Note 13 for discussion of a recently issued accounting pronouncement regarding contingently convertible instruments.

 

LYONs holders have the right to require the Company to repurchase the LYONs on June 5th of 2006, 2011, 2016, 2021 and 2026 at their accreted value on these dates as follows:

 

June 5, 2006

  $349.46

June 5, 2011

  $431.24

June 5, 2016

  $532.16

June 5, 2021

  $656.69

June 5, 2026

  $810.36

 

The Company may choose to pay the purchase price for such repurchases in cash or common shares of the Company. The Company may redeem the LYONs for cash on or after June 5, 2006 at their accreted value.

 

7. Unsecured Senior Notes

 

On August 13, 2004, the Company issued $200 million of 7.35% unsecured senior notes due August 15, 2034. The unsecured senior notes were issued under an existing shelf registration statement. Net proceeds to the Company were $196.8 million and were primarily used to repay $110.0 million outstanding under the Company’s revolving credit facility.

 

9


Table of Contents

8. Comprehensive Income (Loss)

 

Other comprehensive income (loss) is primarily composed of net holding gains (losses) on securities arising during the period less reclassification adjustments for gains (losses) included in net income (loss). Other comprehensive income (loss) also includes foreign currency translation adjustments. The related tax expense (benefit) on net holding gains (losses) on securities arising during the period was $30.2 million and $6.9 million, respectively, for the quarter and nine months ended September 30, 2004 and $(7.1) million and $44.5 million, respectively, for the same periods in 2003. The related tax expense (benefit) on the reclassification adjustments for gains (losses) included in net income (loss) was $(0.1) million and $2.4 million, respectively, for the quarter and nine months ended September 30, 2004 and $(2.6) million and $12.5 million, respectively, for the same periods in 2003. The related tax expense (benefit) on foreign currency translation adjustments was $(0.2) million and $(0.5) million, respectively, for the quarter and nine months ended September 30, 2004 and $(1.5) million and $2.1 million, respectively, for the same periods in 2003.

 

9. Segment Reporting Disclosures

 

The Company operates in three segments of the specialty insurance marketplace: the Excess and Surplus Lines, the Specialty Admitted and the London markets.

 

All investing activities are included in the Investing segment. Discontinued programs and non-strategic insurance subsidiaries are included in Other for purposes of segment reporting.

 

The Company considers many factors, including the nature of the underwriting units’ insurance products, production sources, distribution strategies and regulatory environment in determining how to aggregate operating segments.

 

Segment profit or (loss) for each of the Company’s operating segments is measured by underwriting profit or (loss). The property and casualty insurance industry commonly defines underwriting profit or (loss) as earned premiums net of losses and loss adjustment expenses and underwriting, acquisition and insurance expenses. Underwriting profit or (loss) does not replace operating income (loss) or net income (loss) computed in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) as a measure of profitability. Underwriting profit or (loss) provides a basis for management to evaluate the Company’s underwriting performance. Segment profit for the Investing segment is measured by net investment income and net realized gains or losses.

 

The Company does not allocate assets to the Excess and Surplus Lines, Specialty Admitted and London Insurance Market operating segments for management reporting purposes. The total investment portfolio, cash and cash equivalents are allocated to the Investing segment. The Company does not allocate capital expenditures for long-lived assets to any of its operating segments for management reporting purposes.

 

10


Table of Contents

a) Following is a summary of segment disclosures (dollars in thousands):

 

Quarter Ended September 30, 2004

 

   Excess and
Surplus Lines


  Specialty
Admitted


  London
Insurance
Market


  Investing

  Other

  Consolidated

 

Gross premium volume

  $374,137  $89,953  $170,467  $ —    $5,214  $639,771 

Net premiums written

   292,134   85,312   142,906   —     5,053   525,405 

Earned premiums

  $290,842  $68,632  $152,145  $ —    $10,366  $521,985 

Losses and loss adjustment expenses

   180,972   41,865   148,304   —     10,661   381,802 

Underwriting, acquisition and insurance expenses

   84,839   18,855   61,849   —     3,712   169,255 
   


 


 


 


 


 


Underwriting profit (loss)

   25,031   7,912   (58,008)  —     (4,007)  (29,072)
   


 


 


 


 


 


Net investment income

   —     —     —     51,222   —     51,222 

Net realized losses from investment sales

   —     —     —     (253)  —     (253)
   


 


 


 


 


 


Segment profit (loss)

  $25,031  $7,912  $(58,008) $50,969  $(4,007) $21,897 
   


 


 


 


 


 


Interest expense

                       14,495 
                       


Income before income taxes

                      $7,402 
                       


U.S. GAAP combined ratio*

   91%  89%  138%  —     139%  106%

 

Quarter Ended September 30, 2003

 

   Excess and
Surplus Lines


  Specialty
Admitted


  London
Insurance
Market


  Investing

  Other

  Consolidated

 

Gross premium volume

  $398,581  $81,095  $183,184  $ —    $8,574  $671,434 

Net premiums written

   291,435   76,991   150,257   —     5,101   523,784 

Earned premiums

  $266,800  $60,467  $140,538  $ —    $8,190  $475,995 

Losses and loss adjustment expenses

   185,107   37,892   93,137   —     62,732   378,868 

Underwriting, acquisition and insurance expenses

   80,191   16,494   49,046   —     1,371   147,102 
   


 


 


 


 


 


Underwriting profit (loss)

   1,502   6,081   (1,645)  —     (55,913)  (49,975)
   


 


 


 


 


 


Net investment income

   —     —     —     46,379   —     46,379 

Net realized losses from investment sales

   —     —     —     (7,360)  —     (7,360)
   


 


 


 


 


 


Segment profit (loss)

  $1,502  $6,081  $(1,645) $39,019  $(55,913) $(10,956)

Interest expense

                       13,720 
                       


Loss before income taxes

                      $(24,676)
                       


U.S. GAAP combined ratio*

   99%  90%  101%  —     783%  110%

 

11


Table of Contents

Nine Months Ended September 30, 2004

 

   

Excess and

Surplus Lines


  Specialty
Admitted


  London
Insurance
Market


  Investing

  Other

  Consolidated

 

Gross premium volume

  $1,114,808  $235,728  $548,139  $ —    $38,730  $1,937,405 

Net premiums written

   870,499   222,527   457,018   —     31,293   1,581,337 

Earned premiums

  $857,512  $196,373  $465,517  $ —    $23,401  $1,542,803 

Losses and loss adjustment expenses

   489,152   114,193   383,417   —     23,168   1,009,930 

Underwriting, acquisition and insurance expenses

   249,402   59,578   171,243   —     10,788   491,011 
   


 


 


 

  


 


Underwriting profit (loss)

   118,958   22,601   (89,143)  —     (10,555)  41,861 
   


 


 


 

  


 


Net investment income

   —     —     —     147,910   —     147,910 

Net realized gains from investment sales

   —     —     —     6,937   —     6,937 
   


 


 


 

  


 


Segment profit (loss)

  $118,958  $22,601  $(89,143) $154,847  $(10,555) $196,708 
   


 


 


 

  


 


Interest expense

                       40,317 
                       


Income before income taxes

                      $156,391 
                       


U.S. GAAP combined ratio*

   86%  88%  119%  —     145%  97%

 

Nine Months Ended September 30, 2003

 

   Excess and
Surplus Lines


  Specialty
Admitted


  London
Insurance
Market


  Investing

  Other

  Consolidated

 

Gross premium volume

  $1,135,992  $212,533  $548,762  $ —    $37,738  $1,935,025 

Net premiums written

   812,910   199,778   435,846   —     26,084   1,474,618 

Earned premiums

  $750,716  $172,541  $404,753  $ —    $19,211  $1,347,221 

Losses and loss adjustment expenses

   480,667   105,824   268,742   —     83,587   938,820 

Underwriting, acquisition and insurance expenses

   211,878   54,908   143,977   —     10,132   420,895 
   


 


 


 

  


 


Underwriting profit (loss)

   58,171   11,809   (7,966)  —     (74,508)  (12,494)
   


 


 


 

  


 


Net investment income

   —     —     —     137,079   —     137,079 

Net realized gains from investment sales

   —     —     —     35,843   —     35,843 
   


 


 


 

  


 


Segment profit (loss)

  $58,171  $11,809  $(7,966) $172,922  $(74,508) $160,428 
   


 


 


 

  


 


Amortization of intangible assets

                       4,127 

Interest expense

                       38,756 
                       


Income before income taxes

                      $117,545 
                       


U.S. GAAP combined ratio*

   92%  93%  102%  —     488%  101%

 

*The U.S. GAAP combined ratio is a measure of underwriting performance and represents the relationship of incurred losses, loss adjustment expenses and underwriting, acquisition and insurance expenses to earned premiums.

 

12


Table of Contents
b)The following summary reconciles segment assets to the Company’s consolidated financial statements (dollars in thousands):

 

   As of

   September 30,
2004


  

December 31,

2003


Segment Assets

        

Investing

  $5,918,506  $5,349,952

Other

   3,175,997   3,182,281
   

  

Total Assets

  $9,094,503  $8,532,233

 

10. Income Taxes

 

During the quarter ended September 30, 2004, the Company’s 2000 federal income tax year was closed. As a result, management determined that tax liabilities were $22.5 million less than previously estimated. The Company recognized a nonrecurring tax benefit of $4.1 million, reduced goodwill related to the Markel International acquisition by $14.7 million and increased additional paid in capital related to closed stock option plans by $3.7 million.

 

11. Goodwill and Other Intangible Assets

 

Statement No. 142, Goodwill and Other Intangible Assets, requires goodwill to be tested at least annually for impairment. The Company completes its annual test during the fourth quarter of each year based upon the results of operations through September 30. There was no indication of goodwill impairment as of September 30, 2004 or December 31, 2003.

 

Intangible assets other than goodwill were fully amortized as of June 30, 2003. The amortization expense for intangible assets was $4.1 million for the nine months ended September 30, 2003.

 

The carrying amounts of goodwill by reporting unit at September 30, 2004 were as follows: Excess and Surplus Lines, $81.8 million, and London Insurance Market, $260.8 million. The carrying amounts of goodwill by reporting unit at December 31, 2003 were as follows: Excess and Surplus Lines, $81.8 million, and London Insurance Market, $275.5 million. The carrying amount of goodwill for the London Insurance Market was reduced in the third quarter of 2004 by $14.7 million as discussed in Note 10.

 

12. Contingencies

 

On January 31, 2001, the Company received notice of a lawsuit filed in the United States District Court of the Southern District of New York against Terra Nova Insurance Company Limited by Palladium Insurance Limited and Bank of America, N.A. seeking approximately $27 million plus exemplary damages in connection with alleged reinsurance agreements. The discovery phase of this matter recently ended. The case is not expected to be ready for trial before 2005. The Company believes it has numerous defenses to this claim, including the defense that the alleged reinsurance agreements and insurance policies were not valid. The Company intends to vigorously defend this matter.

 

This and other contingencies arise in the normal conduct of the Company’s operations. In the opinion of management, the resolutions of these contingencies are not expected to have a material impact on the Company’s financial condition or results of operations. However, adverse outcomes are possible and could negatively impact the Company’s financial condition or results of operations.

 

13


Table of Contents

13. Recently Issued Accounting Pronouncement

 

In September 2004, the Financial Accounting Standards Board’s Emerging Issues Task Force (EITF) reached a consensus on EITF Issue No. 04-8 (Issue No. 04-8) which addresses the effect of contingently convertible instruments on diluted earnings per share. The Company’s convertible notes payable are considered to be a contingently convertible instrument based upon the criteria established by Issue No. 04-8. When Issue No. 04-8 becomes effective, the Company will be required to restate previously reported diluted earnings per share. It is anticipated this rule will take effect during the fourth quarter of 2004. If the proposed accounting treatment for the convertible notes payable had been in effect at the end of the third quarter, the Company’s diluted earnings per share for the nine months ended September 30, 2004 would be further diluted by approximately 2%.

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The accompanying consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) and include the accounts of Markel Corporation and all subsidiaries (the Company).

 

Critical Accounting Policies

 

Critical accounting policies are defined as those that are both important to the portrayal of the Company’s financial condition and results of operations and require management to exercise significant judgment. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of material contingent assets and liabilities, including litigation contingencies, at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates, by necessity, are based on assumptions about numerous factors.

 

Management reviews its estimates and assumptions quarterly, including the adequacy of reserves for unpaid losses and loss adjustment expenses and reinsurance allowance for doubtful accounts, as well as the recoverability of deferred tax assets and intangible assets and the evaluation of the investment portfolio for other than temporary declines in value. Actual results may differ materially from the estimates and assumptions used in preparing the consolidated financial statements.

 

Readers are urged to review the Company’s 2003 annual report on Form 10-K for a more complete description of the Company’s critical accounting policies.

 

The Company

 

The Company markets and underwrites specialty insurance products and programs to a variety of niche markets. In each of these markets, the Company seeks to be a market leader. The financial goals of the Company are to earn consistent underwriting profits and superior investment returns to build shareholder value.

 

The Company competes in three segments of the specialty insurance marketplace: the Excess & Surplus Lines, the Specialty Admitted and the London markets. The Excess and Surplus Lines segment is comprised of five underwriting units, the Specialty Admitted segment consists of two underwriting units and the London Insurance Market segment is comprised of the ongoing operations of Markel International.

 

14


Table of Contents

The Excess and Surplus Lines segment writes property and casualty insurance for non-standard and hard-to-place risks including catastrophe-exposed property, professional liability, products liability, general liability, commercial umbrella and other coverages tailored for unique exposures.

 

The Specialty Admitted segment writes risks that are unique and hard-to-place in the standard market but must remain with an admitted insurance company for marketing and regulatory reasons. The underwriting units in this segment write specialty program insurance for well-defined niche markets and personal and commercial property and liability coverages.

 

The Company participates in the London market through Markel Capital Limited and Markel International Insurance Company Limited, two wholly-owned subsidiaries. Markel Capital Limited is the corporate capital provider for Markel Syndicate 3000 at Lloyd’s. Markel Syndicate Management Limited, a wholly-owned subsidiary, manages the Company’s Lloyd’s operations. The London Insurance Market segment writes specialty property, casualty, marine and aviation insurance and reinsurance.

 

Discontinued lines of business and non-strategic insurance subsidiaries are included in Other for segment reporting purposes. Other consisted primarily of discontinued Markel International programs and Corifrance, a wholly-owned subsidiary, for the quarters and nine months ended September 30, 2004 and 2003.

 

Results of Operations

 

The following information presents results of operations for the quarter and nine months ended September 30, 2004 compared to the quarter and nine months ended September 30, 2003.

 

Underwriting Results

 

Following is a comparison of selected data from the Company’s operations (dollars in thousands):

 

   Quarter Ended
September 30,


  Nine Months Ended
September 30,


 
   2004

  2003

  2004

  2003

 

Gross premium volume

  $639,771  $671,434  $1,937,405  $1,935,025 

Net premiums written

   525,405   523,784   1,581,337   1,474,618 

Net retention

   82%  78%  82%  76%

Earned premiums

   521,985   475,995   1,542,803   1,347,221 

Losses and loss adjustment expenses

   381,802   378,868   1,009,930   938,820 

Underwriting, acquisition and insurance expenses

   169,255   147,102   491,011   420,895 

Underwriting profit (loss)*

   (29,072)  (49,975)  41,861   (12,494)
   


 


 


 


U.S. GAAP Combined Ratios

                 

Excess and Surplus Lines

   91%  99%  86%  92%

Specialty Admitted

   89%  90%  88%  93%

London Insurance Market

   138%  101%  119%  102%

Other

   139%  783%  145%  488%

Markel Corporation (Consolidated)

   106%  110%  97%  101%
   


 


 


 


 

*See note 9 of the notes to consolidated financial statements for a discussion of underwriting profit or (loss) and a reconciliation of this amount to income (loss) before income taxes. The property and casualty insurance

 

15


Table of Contents

industry commonly defines underwriting profit or (loss) as earned premiums net of losses and loss adjustment expenses and underwriting, acquisition and insurance expenses. Underwriting profit or (loss) does not replace operating income (loss) or net income (loss) computed in accordance with U.S. GAAP as a measure of profitability.

 

Underwriting profits are a key component of the Company’s strategy to grow book value per share. The Company believes that the ability to achieve consistent underwriting profits demonstrates knowledge and expertise, commitment to superior customer service and the ability to manage insurance risk. The Company uses underwriting profit or (loss) as a basis of evaluating its underwriting performance.

 

The U.S. GAAP combined ratio is a measure of underwriting performance and represents the relationship of incurred losses, loss adjustment expenses and underwriting, acquisition and insurance expenses to earned premiums. A combined ratio of less than 100% indicates an underwriting profit, while a combined ratio of greater than 100% reflects an underwriting loss.

 

The Company reported a combined ratio of 106% and 97%, respectively, for the quarter and nine months ended September 30, 2004 compared to a combined ratio of 110% and 101%, respectively, for the same periods in 2003. For the quarter and nine months ended September 30, 2004, the improved underwriting performance for the Excess and Surplus Lines and Specialty Admitted segments was partially offset by loss development in the London Insurance Market segment. The third quarter and nine month results for 2004 reflected approximately $80 million of pre-tax net losses related to Hurricanes Charley, Frances, Ivan and Jeanne.

 

The combined ratios for the Excess and Surplus Lines segment improved for both the quarter and nine months ended September 30, 2004 and included approximately $26 million of net losses related to the 2004 hurricanes. The improvement for both periods was due to more favorable development of prior years’ loss reserves in 2004 compared to 2003. In 2003, underwriting results included a $50 million increase in prior years’ loss reserves at the Investors Brokered Excess and Surplus Lines unit.

 

The Specialty Admitted segment produced improved underwriting results for the quarter and nine months ended September 30, 2004 compared to the same periods of 2003. The combined ratios for the quarter and nine months ended September 30, 2004 included approximately $9 million of net losses from the 2004 hurricanes. The Specialty Admitted segment continues to benefit from lower current year losses, more favorable development of prior years’ loss reserves and lower expense ratios.

 

The London Insurance Market segment’s combined ratios for the quarter and nine months ended September 30, 2004 included approximately $45.0 million of net losses for the 2004 hurricanes and an $8.0 million provision for dispute resolution. The underwriting loss for the nine months ended September 30, 2004 also included $30.0 million of loss reserve increases reported during the first quarter of 2004.

 

The underwriting loss from Other was $4.0 million for the quarter ended September 30, 2004 compared to $55.9 million for 2003. The Other underwriting loss for the nine months ended September 30, 2004 was $10.6 million compared to $74.5 million for the same period of 2003. During the third quarter of 2004, the Company completed a review of asbestos and environmental exposures in both its U.S. and international operations. While the legal environment and process for resolving asbestos and environmental claims continues to be adverse, no adjustments to loss reserves resulted from this review. The third quarter of 2003 included $55.0 million of reserve increases for asbestos and environmental exposures. Asbestos and environmental reserves are subject to significant uncertainty due to potential loss severity and frequency resulting from the uncertain and

 

16


Table of Contents

unfavorable legal climate. The Company seeks to establish appropriate reserve levels for asbestos and environmental exposures; however, these reserves could be subject to increases in the future.

 

Premiums

 

Following is a comparison of gross premium volume by significant underwriting segment:

 

Gross Premium Volume

 

Quarter Ended September 30,

      Nine Months Ended September 30,

2004

  2003

    

(dollars in thousands)


 2004

  2003

$374,137  $398,581    Excess and Surplus Lines $1,114,808  $1,135,992
 89,953   81,095    Specialty Admitted  235,728   212,533
 170,467   183,184    London Insurance Market  548,139   548,762
 5,214   8,574    Other  38,730   37,738


  

    
 

  

$639,771  $671,434    Total $1,937,405  $1,935,025


  

    
 

  

 

Gross written premium for the third quarter of 2004 declined 5% compared to the same period of 2003. For the nine months ended September 30, 2004, gross written premium was flat compared to 2003. The Company has experienced some market pressure to reduce prices in select lines of business on both new and renewal accounts. When the Company believes the prevailing market rates will not support its underwriting profit targets, the business is not written. The Company will not sacrifice underwriting profits to achieve top line growth and expects 2004 gross premium volume to be flat or slightly down compared to 2003.

 

Following is a comparison of earned premiums by significant underwriting segment:

 

Earned Premiums

 

Quarter Ended September 30,

      Nine Months Ended September 30,

2004

  2003

    

(dollars in thousands)


 2004

  2003

$290,842  $266,800    Excess and Surplus Lines $857,512  $750,716
 68,632   60,467    Specialty Admitted  196,373   172,541
 152,145   140,538    London Insurance Market  465,517   404,753
 10,366   8,190    Other  23,401   19,211


  

    
 

  

$521,985  $475,995    Total $1,542,803  $1,347,221


  

    
 

  

 

Earned premium for the third quarter and nine months ended September 30, 2004 increased 10% and 15%, respectively, compared to the same periods of 2003. This increase in both periods of 2004 is due to higher gross premium volume over the past two years and higher retentions compared to 2003 in all segments.

 

Net Retention

 

The Company purchases reinsurance in order to reduce its retention on individual risks and to enable it to write policies with sufficient limits to meet policyholder needs. The Company’s underwriting philosophy seeks to offer products with limits that do not require significant amounts of reinsurance. Net written premium was $525.4 million for the third quarter of 2004 compared to $523.8 million for the same period of 2003. For the nine months ended September 30, 2004, net written premium was $1.6 billion compared to $1.5 billion in 2003. Net retention of gross written premium has increased, consistent with the Company’s strategy to retain more of its underwriting profits. Net retention of gross written premium for the third quarter of 2004 was 82% compared to 78% for 2003. For the nine months ended September 30, 2004 net retention of gross written premium was 82% compared to 76% for the same period of 2003. The increase was primarily due to changes in the mix of premium writings and purchasing less reinsurance in both the Excess and Surplus Lines and the London Insurance Market segments during 2004 compared to 2003.

 

17


Table of Contents

Investment Results

 

Third quarter 2004 net investment income was $51.2 million compared to $46.4 million in the prior year. Net investment income for the nine months ended September 30, 2004 was $147.9 million compared to $137.1 million in 2003. In both periods of 2004, a larger investment portfolio offset lower investment yields.

 

Net realized losses for the quarter ended September 30, 2004 were $0.3 million compared to $7.4 million in 2003. For the nine months ended September 30, 2004, net realized gains were $6.9 million compared to $35.8 million for the same period last year. Variability in the timing of realized and unrealized investment gains and losses is to be expected.

 

Net realized losses for the quarter ended September 30, 2004 included $1.5 million of realized losses resulting from the write down of two equity securities. For the nine months ended September 30, 2004, net realized gains were partially offset by $3.2 million of realized losses resulting from the write down of three equity securities to their estimated fair value. These securities were deemed by management to have a decline in value that was other than temporary. For the quarter ended September 30, 2003, management determined there were no securities with a decline in value that was other than temporary. For the nine months ended September 30, 2003, net realized gains were partially offset by $15.0 million of realized losses resulting from the write down of one fixed income security and five equity securities to their estimated fair value. At September 30, 2004, the Company held securities with gross unrealized losses of approximately $14.1 million, or significantly less than 1% of the Company’s total investments, cash and cash equivalents. At September 30, 2004, all of these securities were reviewed and the Company believes there were no indications of other than temporary impairment.

 

Other Expenses

 

During the quarter ended September 30, 2004, the Company’s 2000 federal income tax year was closed. As a result, management determined that tax liabilities were $22.5 million less than previously estimated. The Company recognized a nonrecurring tax benefit of $4.1 million, reduced goodwill related to the Markel International acquisition by $14.7 million and increased additional paid in capital related to closed stock option plans by $3.7 million. Without regard to the nonrecurring benefit, the Company’s estimated annual effective tax rate was 29% for the nine months ended September 30, 2004 compared to 33% for the same period in 2003. The Company’s estimated annual effective rate differs from the statutory tax rate of 35% primarily as a result of tax exempt investment income.

 

Comprehensive Income (Loss)

 

Comprehensive income was $69.8 million for the third quarter of 2004 compared to comprehensive loss of $27.7 million for the same period of 2003. The improvement was primarily due to an increase in the market value of the Company’s investment portfolio and higher net income as a result of improved underwriting performance in the third quarter of 2004 compared to the same period of 2003. For the nine months ended September 30, 2004, comprehensive income was $122.4 million compared to $142.1 million in 2003. The decrease in comprehensive income was due to lower unrealized gains on the investment portfolio for the nine months ended September 30, 2004 compared to the same period of 2003 partially offset by higher net income as a result of a return to consolidated underwriting profits in 2004. Comprehensive income for the third quarter of 2004 includes a $0.3 million loss from currency translation adjustments, net of taxes, compared to a loss of $2.8 million for the same period of 2003. For the nine months ended September 30, 2004, the loss from currency translation adjustments, net of taxes, was $1.0 million compared to a gain of $4.0 million for the same period in 2003. The Company attempts to match assets and liabilities in original currencies to mitigate the impact of currency volatility.

 

18


Table of Contents

Financial Condition

 

At September 30, 2004, the Company’s investment portfolio increased approximately 11% to $5.9 billion from $5.3 billion at December 31, 2003. The Company reported net unrealized gains, net of taxes, on its fixed maturity and equity investments of $279.1 million at September 30, 2004 compared to $270.8 million at December 31, 2003. The fair market values of equity securities were $1.1 billion and $968.8 million, respectively, and represented 18% of the total investment portfolio at both September 30, 2004 and December 31, 2003.

 

Net cash provided by operating activities was $493.9 million for the nine months ended September 30, 2004 compared to $450.8 million for the same period in 2003. The increase was primarily due to increased cash flows from the Company’s international operations for the nine months ended September 30, 2004 compared to same period of 2003.

 

For the nine months ended September 30, 2004, the Company reported net cash provided by financing activities of $84.4 million compared to $73.1 million in 2003. The net cash provided by financing activities during the nine months ended September 30, 2004 was primarily due to a debt issuance during the third quarter, partially offset by the repayment of the outstanding balance under the Company’s revolving credit facility and the repurchase of 12,000 shares of the Company’s common stock. These repurchases were made in anticipation of the future issuance of the Company’s common stock to satisfy grants of Restricted Stock Units made to directors and officers under the Markel Corporation Omnibus Incentive Plan. The net cash provided by financing activities during the nine months ended September 30, 2003 was primarily the result of debt issuances during the first and second quarters of 2003, partially offset by the repayment of the outstanding balance under the Company’s revolving credit facility.

 

Prior to December 31, 2004, the Company expects to reallocate capital and liabilities among and between certain wholly-owned subsidiaries of Markel International by means of commutation and reinsurance agreements between the subsidiaries. The Company anticipates this transaction may require a capital contribution to Markel International of approximately $70 million.

 

The Company has access to various liquidity sources including dividends from its insurance subsidiaries, holding company investments and cash, undrawn capacity under its revolving credit facility and access to the debt and equity capital markets. Management believes that the Company has sufficient liquidity to meet its needs.

 

Shareholders’ equity at September 30, 2004 was $1.5 billion compared to $1.4 billion at December 31, 2003. Book value increased 9% to $152.93 per share primarily as a result of $115.1 million of net income for the nine months ended September 30, 2004.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

Market risk is the risk of economic losses due to adverse changes in the estimated fair value of a financial instrument as the result of changes in equity prices, interest rates, foreign exchange rates and commodity prices.

 

19


Table of Contents

The Company’s consolidated balance sheets include assets and liabilities with estimated fair values which are subject to market risk. The primary market risks to the Company are equity price risk associated with investments in equity securities, interest rate risk associated with investments in fixed maturities and foreign exchange risk for its international operations. The Company has no material commodity risk.

 

The Company primarily manages foreign exchange risk by matching assets and liabilities in each foreign currency as closely as possible. Significant estimations and assumptions are required when establishing insurance balances such as reinsurance recoverables and reserves for unpaid losses and loss adjustment expenses. As a result, matching of assets and liabilities by currency is subject to change as actual results emerge.

 

The Company’s market risks at September 30, 2004 have not materially changed from those identified at December 31, 2003.

 

Item 4. Controls and Procedures

 

As of the end of the period covered by this quarterly report, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Chairman and Chief Executive Officer (CEO) and the Executive Vice President and Chief Financial Officer (CFO), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Securities Exchange Act Rule 13a-15 (Disclosure Controls).

 

The Company’s management, including the CEO and CFO, does not expect that its Disclosure Controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

Based upon the Company’s controls evaluation, the CEO and CFO have concluded that the Company’s Disclosure Controls provide reasonable assurance that the information required to be disclosed by the Company in its periodic reports is accumulated and communicated to management, including the CEO and CFO, as appropriate to allow timely decisions regarding disclosure and is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms.

 

There were no changes in the Company’s internal control over financial reporting during the Company’s most recent fiscal quarter that materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

Safe Harbor and Cautionary Statement

 

This is a “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995. It also contains general cautionary statements regarding the Company’s business, estimates and management assumptions.

 

20


Table of Contents

Future actual results may materially differ from those in these statements because of many factors. Among other things:

 

The impact of the events of September 11, 2001 will depend on the number of insureds and reinsureds affected by the events, the amount and timing of losses incurred and reported and questions of how coverage applies;

 

The occurrence of additional terrorist activities could have a material impact on the Company and the insurance industry;

 

The Company’s anticipated premium volume is based on current knowledge and assumes no significant man-made or natural catastrophes, no significant changes in products or personnel and no adverse changes in market conditions;

 

The Company is legally required to offer terrorism insurance and has attempted to manage its exposure; however, in the event of a covered terrorist attack, the Company could sustain material losses;

 

Changing legal and social trends and inherent uncertainties, including but not limited to those uncertainties associated with the Company’s asbestos and environmental reserves, in the loss estimation process can adversely impact the adequacy of loss reserves and the allowance for reinsurance recoverables;

 

Industry and economic conditions can affect the ability and/or willingness of reinsurers to pay balances due;

 

The Company continues to closely monitor discontinued lines and reinsurance programs and exposures. Adverse experience in these areas could lead to additional charges;

 

Regulatory actions can impede the Company’s ability to charge adequate rates and efficiently allocate capital; and

 

Economic conditions, interest rates and foreign exchange rate volatility and concentration of investments can have a significant impact on the market value of fixed maturity and equity investments, as well as the carrying value of other assets and liabilities.

 

The Company’s premium volume, underwriting and investment results have been and will continue to be potentially materially affected by these factors. Additional factors, which could affect the Company, are discussed in the Company’s reports on Forms 8-K, 10-Q and 10-K. By making these forward-looking statements, the Company is not intending to become obligated to publicly update or revise any forward-looking statements whether as a result of new information, future events or other changes. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as at their dates.

 

PART II. OTHER INFORMATION

 

Item 6. Exhibits

 

See Exhibit Index for a list of Exhibits filed as part of this report.

 

21


Table of Contents

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized, this 3rd day of November, 2004.

 

The Company
By 

/s/ Alan I. Kirshner


  Alan I. Kirshner
  Chairman and Chief Executive Officer
  (Principal Executive Officer)
By 

/s/ Anthony F. Markel


  Anthony F. Markel
  President
  (Principal Operating Officer)
By 

/s/ Steven A. Markel


  Steven A. Markel
  Vice Chairman
By 

/s/ Darrell D. Martin


  Darrell D. Martin
  Executive Vice President and
  Chief Financial Officer
  (Principal Financial Officer and
  Principal Accounting Officer)

 

22


Table of Contents

Exhibit Index

 

Number

 

Description


    3(i) Amended and Restated Articles of Incorporation, as amended (3(i))a
    3(ii) Bylaws, as amended (4.2)b
    4 Credit Agreement dated September 30, 2003, among Markel Corporation, the lenders named therein and SunTrust Bank, as Administrative Agent (4)c
  The registrant hereby agrees to furnish to the Securities and Exchange Commission a copy of all instruments defining the rights of holders of convertible notes payable and long-term debt of the registrant and subsidiaries shown on the Consolidated Balance Sheet of the registrant at September 30, 2004 and the respective Notes thereto, included in the Quarterly Report on Form 10-Q.
    31.1 Certification of Principal Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a)*
    31.2 Certification of Principal Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a)*
    32.1 Certification of Principal Executive Officer furnished Pursuant to 18 U.S.C. Section 1350*
    32.2 Certification of Principal Financial Officer furnished Pursuant to 18 U.S.C. Section 1350*

 

a.Incorporated by reference from the exhibit shown in parentheses filed with the Commission in the Registrant’s report on Form 10-Q for the quarter ended March 31, 2000.
b.Incorporated by reference from Exhibit 4.2 to S-8 Registration Statement No. 333-107661, dated

August 5, 2003.

c.Incorporated by reference from the exhibit shown in parentheses filed with the Commission in the Registrant’s report on Form 10-Q for the quarter ended September 30, 2003.
*Filed with this report.

 

23